| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.005 |